Neutrophil lymphocyte ratio and platelet lymphocyte ratio as a marker for disease severity in children with COVID-19

Authors

  • Attia Bari Department of Pediatric Medicine, University of Child health Sciences, The Children Hospital Lahore, Pakistan
  • Tooba Fateen Department of Pathology. University of Child health Sciences, The Children Hospital Lahore, Pakistan
  • Aimen Ch Department of Pediatric Medicine, University of Child health Sciences, The Children Hospital Lahore, Pakistan

DOI:

https://doi.org/10.18203/2349-3291.ijcp20233953

Keywords:

COVID-19, MIS-C, Children, Blood picture, Neutrophil, Platelet

Abstract

Background: It had been observed that there is relationship of neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) with disease severity in children with COVID-19 and post-COVID, multisystem inflammatory disease in children (MIS-C).  Study conducted to determine NLR and PLR correlation with this disease severity.

Methods: Prospective descriptive analytical study conducted at the children’s hospital and university of child health sciences, Lahore. Consecutive confirmed cases of COVID-19 infection and post-COVID, MIS-C diagnosed on the basis of RT-PCR from nasopharyngeal swab and antibody test admitted from March 2020 to October 2021 were included through consecutive sampling. Complete blood (CBC) was done and NLR and PLR was determined

Results: Majority 198 (74.2%) of the 267 patients had a diagnosis of COVID-19 and 69 (25.8%) were post-COVID MIS-C. There was a male preponderance 177 (66.3%) and the mean age was 6.1±4.7 years (95% CI: 5.62-6.74). Majority children had mild disease 80 (30%), 34 (12.7%) were critical and there were 37 (13.8%) deaths. Underlying comorbidity was present in 55 (20.6%). As the severity of symptoms changed from asymptomatic to severe disease, there was a significant rise of mean NLR from 1.88±1.40 to 5.47±4.77 respectively (p<0.001). PLR however, failed to show any kind of association with severity of the symptoms (p=0.922).

Conclusions: NLR served as a marker of disease severity among pediatric patients suffering from COVID-19 and MIS-C. However, PLR failed to show any relation with disease severity.

References

Sharma A, Tiwari S, Deb MK, Marty JL. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrobial Agents. 2020;56(2):106054.

Sadiq M, Aziz OA, Kazmi U, Hyder N, Sarwar M, Sultana N et al. Multisystem inflammatory syndrome associated with COVID-19 in children in Pakistan. Lancet Child Adolescent Heal. 2020;4(10):e36-7.

El-Kady AM, Aldakheel FM. Clinical Characteristics, Outcomes and Prognostic Factors for Critical Illness in Hospitalized COVID-19 Patients in Saudi Arabia: A Retrospective Cohort Study. 2022;15:6945-63.

Wool GD, Miller JL. The Impact of COVID-19 Disease on Platelets and Coagulation. Pathobiology. J Immunopathology. Molecular Cellular Biol. 2021;88(1):15-27.

Chan AS, Rout A. Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19. J Clin Med Res. 2020;12(7):448-53.

Wang X, Li X, Shang Y, Wang J, Zhang X, Su D et al. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre. Epidemiol Infect. 2020;148:e211.

Xia LJ, Li W, Zhai JC, Yan CW, Chen JB, Yang H. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer. BMC Cancer. 2020;20(1):208.

Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504.

Li Y, Guo F. Insight into COVID-2019 for pediatricians. Pediatr Pulmonol. 2020;55(5):E1-4.

Asghar MS, Asghar MZ, Zahid A, Shah HSZA, Khan H, Zia H. Inflammatory mediators as surrogates of malignancy. J Pak Med Asso. 2022;72(11):2259-63.

Jia D, Liu F, Zhang Q, Zeng GQ, Li XL, Hou G. Rapid on-site evaluation of routine biochemical parameters to predict right ventricular dysfunction in and the prognosis of patients with acute pulmonary embolism upon admission to the emergency room. J Clin Lab Anal. 2018;32(4):e22362.

Pimentel GD, Dela Vega MCM, Laviano A. High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients. Clin Nutrit ESPEN. 2020;40:101-2.

Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1):206.

Yildiz E, Cigri E, Dincer Z, Narsat MA, Calisir B. High Neutrophil/Lymphocyte Ratios in Symptomatic Pediatric COVID-19 Patients. J College Physicians Surgeons-Pak. 2021;31(7):S93-8.

Ying H-Q, Deng Q-W, He B-S, Pan Y-Q, Wang F, Sun H-L et al. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Med Oncol. 2014;31:1-8.

Uslu AU, Küçük A, Şahin A, Ugan Y, Yılmaz R, Güngör T et al. Two new inflammatory markers associated with Disease Activity Score‐28 in patients with rheumatoid arthritis: neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio. Int J Rheumatic Dis. 2015;18(7):731-5.

Jeon YL, Lee W-I, Kang SY, Kim MH. Neutrophil-to-monocyte-plus-lymphocyte ratio as a potential marker for discriminating pulmonary tuberculosis from nontuberculosis infectious lung diseases. Lab Med. 2019;50(3):286-91.

Sun S, Cai X, Wang H, He G, Lin Y, Lu B et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clinica chimica acta. Int J Clin Chem. 2020;507:174-80.

Seyit M, Avci E, Nar R, Senol H, Yilmaz A, Ozen M et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emergency Med. 2021;40:110-4.

Wang R, He M, Yin W, Liao X, Wang B, Jin X et al. The Prognostic Nutritional Index is associated with mortality of COVID-19 patients in Wuhan, China. Cell Biol Int. 2020;34(10):e23566.

Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduction Targeted Therapy. 2020;5(1):33.

Barale C, Melchionda E, Morotti A. Prothrombotic Phenotype in COVID-19: Focus on Platelets. Int J Mol Sci. 2021;22(24).

Yang X, Yang Q, Wang Y, Wu Y, Xu J, Yu Y et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J Thrombosis Haemostasis. 2020;18(6):1469-72.

Li Q, Cao Y, Chen L, Wu D, Yu J, Wang H et al. Hematological features of persons with COVID-19. Leukemia. 2020;34(8):2163-72.

Saqlain N, Bari A, Aimen C, Sadiq M. D-dimer: a biomarker for predicting disease severity and outcome in hospitalized children with COVID-19 and post COVID multisystem inflammatory syndrome. Int J Contemp Pediatr. 2023;10:995-1001.

Downloads

Published

2023-12-28

Issue

Section

Original Research Articles